Akynzeo (Netupitant + palonosetron)

netupitant 300 mg + palonosetron 500 microgram capsule, 1 · ORAL · PBS code 10731T

STREAMLINED

What it costs

AU$81.66 PBS-determined price per 1 units

Most patients pay only the standard PBS co-payment, not the full price above — up to AU$25.00 per script (general) or AU$7.70 (concession/Safety Net) in 2026. The figure above is what the PBS pays the pharmacy; the Australian Government subsidises the rest. Always confirm the current amount with your pharmacist.

• First listed on the PBS: 2016-04-01.
• Repeats: 5.
• PBS program: GE.

Eligibility criteria for subsidised access

The following is the government's own wording from the PBS Schedule, shown unchanged.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Nausea and vomiting

The treatment must be in combination with dexamethasone, unless contraindicated; AND

The treatment must be for prevention of nausea and vomiting associated with moderate to highly emetogenic anti-cancer therapy.

Sponsor: Arrotex Pharmaceuticals Pty Ltd ABN 30 605 552 234

Not medical advice. Voxsanity republishes public PBS data in plain English. PBS listing status and criteria can change; always confirm current subsidised availability with your doctor or pharmacist.

Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.